IHF provides well-rounded, cap-weighted exposure to US companies engaged in managed health care, facilities and insurance. This niche segment excludes pharmaceutical companies that have a heavy hand in the broader US Health Care segment. IHF diverges from our neutral benchmark exposure by including health insurance companies absent from our benchmark, and it tilts smaller. Overall, IHF's diverse holdings provide great comprehensive coverage of the health care provider space.